Selected research
Market Structure
Global Codeine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Codeine Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Codeine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Codeine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Codeine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Codeine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Codeine Drug include Apotex, Aristo Pharma GmbH, Cipla, Hikma, Laboratoire Riva, Lannett Company, Mallinckrodt, Medreich and Pharmaceutical Associates, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Codeine Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Codeine Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Codeine Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Codeine Drug market size, projected growth trends, production technologies, key applications, and end-use industries.
Codeine Drug Segment by Company
Apotex
Aristo Pharma GmbH
Cipla
Hikma
Laboratoire Riva
Lannett Company
Mallinckrodt
Medreich
Pharmaceutical Associates
Sanofi Aventis
Taiji
Viatris
Novartis
Johnson & Johnson
TEVA
Codeine Drug Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications Codeine
Codeine Drug Segment by Application
Narcotic Analgesic
Antitussive
Others
Codeine Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Codeine Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Codeine Drug industry.
Chapter 3: Detailed analysis of Codeine Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Codeine Drugrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-ingredient Codeine
- Multi-ingredient Medications Codeine
Applications
- Narcotic Analgesic
- Antitussive
- Others
Companies covered
- Apotex
- Aristo Pharma GmbH
- Cipla
- Hikma
- Laboratoire Riva
- Lannett Company
- Mallinckrodt
- Medreich
- Pharmaceutical Associates
- Sanofi Aventis
- Taiji
- Viatris
- Novartis
- Johnson & Johnson
- TEVA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Codeine Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Single-ingredient Codeine
- 1.2.3 Multi-ingredient Medications Codeine
- 1.3 Market Analysis by Application
- 1.3.1 Global Codeine Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Narcotic Analgesic
- 1.3.3 Antitussive
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Codeine Drug Growth Trends by Region
- 1.5.1 Global Codeine Drug Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Codeine Drug Market Size by Region (2021-2026)
- 1.5.3 Codeine Drug Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Codeine Drug Market Dynamics
- 2.1 Codeine Drug Industry Trends
- 2.2 Codeine Drug Industry Drivers
- 2.3 Codeine Drug Industry Opportunities and Challenges
- 2.4 Codeine Drug Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Codeine Drug Revenue by Company (2021-2026)
- 3.2 Global Codeine Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Codeine Drug Key Company Head office and Area Served
- 3.4 Global Codeine Drug Company, Product Type & Application
- 3.5 Global Codeine Drug Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Codeine Drug Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Codeine Drug Players Market Share by Revenue in 2025
- 3.6.3 2025 Codeine Drug Tier 1, Tier 2, and Tier 3
4 Codeine Drug Market by Type
- 4.1 Global Codeine Drug Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Codeine Drug Market Size by Type (2021-2032)
- 4.3 Global Codeine Drug Market Size Share by Type (2021-2032)
5 Codeine Drug Market by Application
- 5.1 Global Codeine Drug Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Codeine Drug Market Size by Application (2021-2032)
- 5.3 Global Codeine Drug Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Apotex
- 6.1.1 Apotex Company Information
- 6.1.2 Apotex Business Overview
- 6.1.3 Apotex Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Apotex Codeine Drug Product Portfolio
- 6.1.5 Apotex Recent Developments
- 6.2 Aristo Pharma GmbH
- 6.2.1 Aristo Pharma GmbH Company Information
- 6.2.2 Aristo Pharma GmbH Business Overview
- 6.2.3 Aristo Pharma GmbH Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Aristo Pharma GmbH Codeine Drug Product Portfolio
- 6.2.5 Aristo Pharma GmbH Recent Developments
- 6.3 Cipla
- 6.3.1 Cipla Company Information
- 6.3.2 Cipla Business Overview
- 6.3.3 Cipla Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Cipla Codeine Drug Product Portfolio
- 6.3.5 Cipla Recent Developments
- 6.4 Hikma
- 6.4.1 Hikma Company Information
- 6.4.2 Hikma Business Overview
- 6.4.3 Hikma Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Hikma Codeine Drug Product Portfolio
- 6.4.5 Hikma Recent Developments
- 6.5 Laboratoire Riva
- 6.5.1 Laboratoire Riva Company Information
- 6.5.2 Laboratoire Riva Business Overview
- 6.5.3 Laboratoire Riva Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Laboratoire Riva Codeine Drug Product Portfolio
- 6.5.5 Laboratoire Riva Recent Developments
- 6.6 Lannett Company
- 6.6.1 Lannett Company Company Information
- 6.6.2 Lannett Company Business Overview
- 6.6.3 Lannett Company Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Lannett Company Codeine Drug Product Portfolio
- 6.6.5 Lannett Company Recent Developments
- 6.7 Mallinckrodt
- 6.7.1 Mallinckrodt Company Information
- 6.7.2 Mallinckrodt Business Overview
- 6.7.3 Mallinckrodt Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Mallinckrodt Codeine Drug Product Portfolio
- 6.7.5 Mallinckrodt Recent Developments
- 6.8 Medreich
- 6.8.1 Medreich Company Information
- 6.8.2 Medreich Business Overview
- 6.8.3 Medreich Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Medreich Codeine Drug Product Portfolio
- 6.8.5 Medreich Recent Developments
- 6.9 Pharmaceutical Associates
- 6.9.1 Pharmaceutical Associates Company Information
- 6.9.2 Pharmaceutical Associates Business Overview
- 6.9.3 Pharmaceutical Associates Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Pharmaceutical Associates Codeine Drug Product Portfolio
- 6.9.5 Pharmaceutical Associates Recent Developments
- 6.10 Sanofi Aventis
- 6.10.1 Sanofi Aventis Company Information
- 6.10.2 Sanofi Aventis Business Overview
- 6.10.3 Sanofi Aventis Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Sanofi Aventis Codeine Drug Product Portfolio
- 6.10.5 Sanofi Aventis Recent Developments
- 6.11 Taiji
- 6.11.1 Taiji Company Information
- 6.11.2 Taiji Business Overview
- 6.11.3 Taiji Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Taiji Codeine Drug Product Portfolio
- 6.11.5 Taiji Recent Developments
- 6.12 Viatris
- 6.12.1 Viatris Company Information
- 6.12.2 Viatris Business Overview
- 6.12.3 Viatris Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Viatris Codeine Drug Product Portfolio
- 6.12.5 Viatris Recent Developments
- 6.13 Novartis
- 6.13.1 Novartis Company Information
- 6.13.2 Novartis Business Overview
- 6.13.3 Novartis Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Novartis Codeine Drug Product Portfolio
- 6.13.5 Novartis Recent Developments
- 6.14 Johnson & Johnson
- 6.14.1 Johnson & Johnson Company Information
- 6.14.2 Johnson & Johnson Business Overview
- 6.14.3 Johnson & Johnson Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Johnson & Johnson Codeine Drug Product Portfolio
- 6.14.5 Johnson & Johnson Recent Developments
- 6.15 TEVA
- 6.15.1 TEVA Company Information
- 6.15.2 TEVA Business Overview
- 6.15.3 TEVA Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 TEVA Codeine Drug Product Portfolio
- 6.15.5 TEVA Recent Developments
7 North America
- 7.1 North America Codeine Drug Market Size (2021-2032)
- 7.2 North America Codeine Drug Market Size by Type
- 7.2.1 North America Codeine Drug Market Size by Type (2021-2026)
- 7.2.2 North America Codeine Drug Market Size by Type (2027-2032)
- 7.2.3 North America Codeine Drug Market Share by Type (2021-2032)
- 7.3 North America Codeine Drug Market Size by Application
- 7.3.1 North America Codeine Drug Market Size by Application (2021-2026)
- 7.3.2 North America Codeine Drug Market Size by Application (2027-2032)
- 7.3.3 North America Codeine Drug Market Share by Application (2021-2032)
- 7.4 North America Codeine Drug Market Size by Country
- 7.4.1 North America Codeine Drug Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Codeine Drug Market Size by Country (2021-2026)
- 7.4.3 North America Codeine Drug Market Size by Country (2027-2032)
- 7.4.4 North America Codeine Drug Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Codeine Drug Market Size (2021-2032)
- 8.2 Europe Codeine Drug Market Size by Type
- 8.2.1 Europe Codeine Drug Market Size by Type (2021-2026)
- 8.2.2 Europe Codeine Drug Market Size by Type (2027-2032)
- 8.2.3 Europe Codeine Drug Market Share by Type (2021-2032)
- 8.3 Europe Codeine Drug Market Size by Application
- 8.3.1 Europe Codeine Drug Market Size by Application (2021-2026)
- 8.3.2 Europe Codeine Drug Market Size by Application (2027-2032)
- 8.3.3 Europe Codeine Drug Market Share by Application (2021-2032)
- 8.4 Europe Codeine Drug Market Size by Country
- 8.4.1 Europe Codeine Drug Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Codeine Drug Market Size by Country (2021-2026)
- 8.4.3 Europe Codeine Drug Market Size by Country (2027-2032)
- 8.4.4 Europe Codeine Drug Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Codeine Drug Market Size (2021-2032)
- 9.2 China Codeine Drug Market Size by Type
- 9.2.1 China Codeine Drug Market Size by Type (2021-2026)
- 9.2.2 China Codeine Drug Market Size by Type (2027-2032)
- 9.2.3 China Codeine Drug Market Share by Type (2021-2032)
- 9.3 China Codeine Drug Market Size by Application
- 9.3.1 China Codeine Drug Market Size by Application (2021-2026)
- 9.3.2 China Codeine Drug Market Size by Application (2027-2032)
- 9.3.3 China Codeine Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Codeine Drug Market Size (2021-2032)
- 10.2 Asia Codeine Drug Market Size by Type
- 10.2.1 Asia Codeine Drug Market Size by Type (2021-2026)
- 10.2.2 Asia Codeine Drug Market Size by Type (2027-2032)
- 10.2.3 Asia Codeine Drug Market Share by Type (2021-2032)
- 10.3 Asia Codeine Drug Market Size by Application
- 10.3.1 Asia Codeine Drug Market Size by Application (2021-2026)
- 10.3.2 Asia Codeine Drug Market Size by Application (2027-2032)
- 10.3.3 Asia Codeine Drug Market Share by Application (2021-2032)
- 10.4 Asia Codeine Drug Market Size by Country
- 10.4.1 Asia Codeine Drug Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Codeine Drug Market Size by Country (2021-2026)
- 10.4.3 Asia Codeine Drug Market Size by Country (2027-2032)
- 10.4.4 Asia Codeine Drug Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Codeine Drug Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Codeine Drug Market Size by Type
- 11.2.1 South America, Middle East & Africa Codeine Drug Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Codeine Drug Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Codeine Drug Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Codeine Drug Market Size by Application
- 11.3.1 South America, Middle East & Africa Codeine Drug Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Codeine Drug Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Codeine Drug Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Codeine Drug Market Size by Country
- 11.4.1 South America, Middle East & Africa Codeine Drug Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Codeine Drug Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Codeine Drug Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Codeine Drug Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst